Wednesday, May 22, 2024
wellness India Expo


Stempeucel, first ‘Made in India’ cell therapy to treat Critical Limb...

Developed by Stempeutics over a period of twelve years, the breakthrough treatment designed to address the root cause of Critical Limb Ischemia at an affordable cost will be marketed and distributed in India by Cipla.....................

“Time ripe for Indian stem cells industry to regenerate its strength”

Mr B N Manohar, Chief Executive Officer, Stempeutics dismisses the claims that Indian stem cells industry hasn’t achieved much and is at the verge of fading out. Read his detailed interview with the Biovoice News.

CDSCO approves first autologous dendritic cell-based immuno-oncology product

APAC Biotech was granted with a commercial license by CDSCO to market its product, APCEDEN, a dendritic cell-based autologous immuno-oncology product for four cancer indications....